Clinical Trial Update: Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

View source ↗

Summary

Terlipressin was studied in a completed trial for combined hepatorenal syndrome in patients with signs of chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hepatorenal Syndrome
• Liver Cirrhosis

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Liver Cirrhosis, Hepato-Renal Syndrome | Status: COMPLETED